Chemoinformaics analysis of 5-[(1R)-1-(2-HYDROXYPHENYL)PROP-2-ENYL]-2,4-DIMETHOXYPHENOL
Molecular Weight | 286.327 | nRot | 5 |
Heavy Atom Molecular Weight | 268.183 | nRig | 13 |
Exact Molecular Weight | 286.121 | nRing | 2 |
Solubility: LogS | -3.532 | nHRing | 0 |
Solubility: LogP | 3.117 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 2 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
nHA | 4 | APOL | 43.6003 |
nHD | 2 | BPOL | 21.5297 |
QED | 0.827 |
Synth | 2.959 |
Natural Product Likeliness | 0.966 |
NR-PPAR-gamma | 0.669 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.061 |
Pgp-sub | 0.013 |
HIA | 0.005 |
CACO-2 | -4.699 |
MDCK | 0.0000185 |
BBB | 0.024 |
PPB | 0.989804 |
VDSS | 0.581 |
FU | 0.0126123 |
CYP1A2-inh | 0.618 |
CYP1A2-sub | 0.961 |
CYP2c19-inh | 0.825 |
CYP2c19-sub | 0.886 |
CYP2c9-inh | 0.832 |
CYP2c9-sub | 0.937 |
CYP2d6-inh | 0.777 |
CYP2d6-sub | 0.91 |
CYP3a4-inh | 0.807 |
CYP3a4-sub | 0.833 |
CL | 9.539 |
T12 | 0.713 |
hERG | 0.017 |
Ames | 0.045 |
ROA | 0.509 |
SkinSen | 0.42 |
Carcinogencity | 0.207 |
EI | 0.853 |
Respiratory | 0.893 |
NR-Aromatase | 0.636 |
Antiviral | Yes |
Prediction | 0.698186 |